NCT04077307View on ClinicalTrials.gov

A Study in Leukemia Patients With Karonudib

PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 3, 2019

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Leukemia
Interventions
DRUG

Karonudib

First part of the study - four different dose cohorts Extension part of the study - karonudib BID (twice a week) and Idarubicin days 1-3.

Trial Locations (2)

Unknown

RECRUITING

Karolinska University Hospital, Huddinge

RECRUITING

Örebro University Hospital, Örebro

All Listed Sponsors
lead

Thomas Helleday Foundation

OTHER

NCT04077307 - A Study in Leukemia Patients With Karonudib | Biotech Hunter | Biotech Hunter